Pentax 2015 Annual Report Download - page 5

Download and view the complete annual report

Please find page 5 of the 2015 Pentax annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 32

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32

Performance in Fiscal 2015
The Life Care Segment Reports Increases in Revenue and Profit
The Life Care Segment recorded revenue of ¥306.6 billion (up
15.5% year on year). The eyeglass lenses business reported a
large increase in revenue overall, as revenues, principally in
overseas markets, expanded, and Seiko Optical Products
(Seiko Eyeglass Lenses Sales) was consolidated into the HOYA
Group as of March 31, 2014. Retail revenues from contact
lenses decreased because of the reactionary decline in sales
that followed in the wake of the surge in demand prior to the
increase in Japan’s consumption tax. Sales of endoscopes,
which were strong in the previous fiscal year, in Russia, the
Middle East, and elsewhere remained at the level of the prior
fiscal year in reaction to unstable conditions in those regions.
However, eyeglass lenses were a major growth driver, and, in
the Life Care business segment as a whole, revenues showed
a major increase over the previous year. Segment pretax profit
amounted to ¥52.9 billion, an increase of 6.5%, or ¥3.2 billion.
The ratio of pretax profit to revenues was 17.3%
Long-Term Stable Growth Is Expected in the Life Care Segment
HOYA Life Care is focused on two domains. These are the eye-
related product markets and low-invasive medical devices. In
the eye-related field, HOYA is focused on eyeglass lenses and
contact lenses which are part of our daily lives and play an
important role in our lives and intraocular lenses for the
treatment of cataracts, enabling us to see. In the low-invasive
device field, we have applied the optical technology that we
have developed in the medical field to develop endoscopes,
which contribute to early discovery and treatment of diseases,
laparoscopic surgical instruments, endoscope reprocessors,
prosthetic fillers, and orthopedics implants.
Copyright ©2015 HOYA GROUP